A Distributor of Salmonella Contaminated Papayas Identified

FDA released an update regarding the ongoing Salmonella outbreak associated with papayas.  At this point, the FDA investigation "indicates that Agroson’s LLC of Bronx, New York, is the exclusive distributor of the imported papayas that likely made consumers from this outbreak sick. The papayas are sold under the brand name Cavi. To date, there have been no positive product samples."

With this, FDA lifts the hold on Mexican papayas.  There was no indication in the notice where the NY distributor sourced the papayas.

To date, there have been 71 cases with 27 hospitalizations,  All cases originated in the northeastern section of the US.

https://www.fda.gov/food/outbreaks-foodborne-illness/salmonella-uganda-likely-linked-whole-fresh-papayas-june-2019
Salmonella Uganda Likely Linked to Whole, Fresh Papayas, June 2019
Consumers in all states warned to avoid Cavi brand whole, fresh papayas distributed by Agroson’s LLC
Case Counts
Total Illnesses: 71
Hospitalizations: 27
Deaths: 0
Last illness onset: June 16, 2019
States with Cases: CT (14), FL (1), MA (5), NJ (18), NY (27), PA (4), RI (1), TX (1)

July 5, 2019


The U.S. Food and Drug Administration (FDA), along with the Centers for Disease Control and Prevention (CDC), and state and local partners, are investigating a multistate outbreak of Salmonella Uganda illnesses likely linked to whole, fresh papayas.

The epidemiological and traceback information collected thus far in the investigation indicates that Agroson’s LLC of Bronx, New York, is the exclusive distributor of the imported papayas that likely made consumers from this outbreak sick. The papayas are sold under the brand name Cavi. To date, there have been no positive product samples.

Of the 71 illnesses, 69 have been reported in six states in the Northeast. One patient from Florida who was reported ill had traveled to Connecticut before becoming ill. Another patient from Texas who was also reported ill had traveled to New York before becoming ill.

The FDA has consulted with the firm on the possibility of a recall. Should that happen, the FDA will update this advisory, including any recalled products, as more information becomes available.

The evidence does not indicate that papayas from other distributors are implicated at this time, and FDA is narrowing its recommendations to consumers, restaurants, retailers, importers, suppliers and distributors, limited to Cavi brand whole, fresh papayas. The FDA will continue its investigation to try to determine the root cause of the contamination of the implicated brand.